Vumon Articles
FDA Panel Backs New Use For Intron A
23 October 1997
Sandoz MDR Drug Shows Promise In Early Trials
13 November 1995
Topo I Inhibitors Show Potential In SCLC
6 November 1995
FDA APPROVES 26 NEWDRUGS IN 1992
25 January 1993
US RESULTS 3RD QTR
2 November 1992
B-MS' VUMON APPROVED IN USA
3 August 1992
Showing 1-7 of 7 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
